用于制备mRNA-LNP的封装后方法
Joanna Duffrène1, Chloé Muzard1,2, Johanne Seguin1
1Université Paris Cité, CNRS, INSERM, Unité des Technologies Chimiques et Biologiques pour la Santé (UTCBS), Paris, 75006, France.
Drug delivery and translational research
|May 6, 2025
概括
创建带有信使RNA的脂质纳米粒子 (mRNA-LNP) 的新方法可以减少废物和材料成本. 封装后的技术产生了mRNA-LNP,其特性和有效性与传统的微流体方法相比较.
科学领域:
- 生物技术是生物技术.
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 微流体是生产mRNA载脂纳米粒子 (mRNA-LNP) 的标准,因为它具有可重复性.
- 然而,微流体方法会产生大量的材料浪费,特别是用于小规模的研究和配方选.
- 合成mRNA的高成本加剧了目前方法的经济局限性.
研究的目的:
- 开发替代性,具有成本效益的方法,以研究规模生产mRNA-LNP.
- 为了提高mRNA-LNP的稳定性,用于配方选,并减少材料浪费.
- 作为一种可行的替代方案,研究将mRNA后封装成预先形成的囊泡 (PFV).
主要方法:
- 预先形成的囊泡 (PFVs) 使用微流体混合生成.
- 用微流体或手动管道方法将mRNA封装到PFV中.
- 由此产生的mRNA-LNP以物理化学性质,形态学和体外/体内表达水平进行了表征.
主要成果:
- 通过封装后产生的mRNA-LNP显示了与传统生产的mRNA-LNP相似的物理化学特性和形态.
- 微流体和手动输管后封装方法都导致了可比的体外和体内传染效率.
- 这些方法的适用性在不同的脂质,mRNA类型和微流体系统中得到证实.
结论:
- 封装后为小规模mRNA-LNP制备提供了强大,简单和经济的替代方案.
- 这些方法减少了材料浪费,并使有效的配方选成为可能.
- 封装后的多功能性促进了个性化的mRNA疗法,允许量身定制的剂量和结构.
相关概念视频
Pre-mRNA Processing: Modification of pre-mRNA Ends
9.1K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
9.1K
pre-mRNA Processing
52.3K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
52.3K
mRNA Stability and Gene Expression
5.5K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.5K
Nuclear Export of mRNA
7.5K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.5K
RNA Splicing
55.7K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
55.7K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K


